Annual report [Section 13 and 15(d), not S-K Item 405]

Note 14 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.25.4
Note 14 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Depreciation and other $ 297 $ 119
Net operating loss carryforwards 57,646 54,001
Research and development tax credits 2,210 2,210
Accruals and reserves 245 235
Capitalized research and development costs 1,360 1,817
Deferred revenue 431 400
Stock compensation expense 648 1,028
Lease assets 82 154
Other 41 48
Lease liabilities (70) (133)
Prepaid expenses (45) (54)
Less: Valuation allowance (62,845) (59,825)
Net deferred tax asset (liability) $ 0 $ 0